Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
基本信息
- 批准号:9313963
- 负责人:
- 金额:$ 42.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2018-05-31
- 项目状态:已结题
- 来源:
- 关键词:AgonistAnti-Inflammatory AgentsAnti-inflammatoryBrainCell DeathCell LineCellsCessation of lifeChronicCytokine SignalingDiseaseDopaminergic CellDoseFunctional disorderGenesHumanIL-13Ralpha1IL13RA1 geneImmune systemIn VitroInflammationInjection of therapeutic agentInterleukin-13Interleukin-4Knockout MiceLigandsMediatingMediator of activation proteinMicrogliaModelingMolecularMusNerve DegenerationNeurodegenerative DisordersNeuronsOxidative StressParkinson DiseasePathogenesisPeripheralPlayPredispositionReactive Oxygen SpeciesReporterRoleSignal PathwaySignal TransductionSignaling MoleculeSourceStressSubstantia nigra structureSystemTestingToxic effectTransgenic MiceX Chromosomebasecytokinedopaminergic neuronexperimental studyin vivoneuroinflammationneuron lossneurotoxicnew therapeutic targetnovelpars compactapublic health relevancereceptor
项目摘要
DESCRIPTION (provided by applicant): We hypothesize that the anti-inflammatory cytokines IL-13 and IL-4 play an important role in the death of dopaminergic neurons in the Substantia nigra pars compacta (SNc), the same cells that are lost in human Parkinson's disease (PD). This hypothesis is based on our preliminary studies in mice which showed that interleukin 13 receptor alpha 1 chain (IL-13Ralpha1), is highly expressed in DA neurons in the SNc and that mice that are deficient is this receptor are protected from the loss of dopaminergic (DA) neurons that occurs during chronic peripheral injection with low doses of LPS. Furthermore, in vitro studies using a dopaminergic cell line showed that while IL-13 alone does not have harmful effects on DA neurons, it strongly potentiates the toxicity of mild oxidative stress. Similar resuls were obtained with IL-4, another cytokine capable of activating IL- 13Ralpha1-dependent signaling. Together these results suggest a novel mechanism whereby anti-inflammatory cytokines can contribute to neuronal loss under conditions of stress. We propose to investigate our hypothesis in three specific aims. In SA1, we will determine how the interaction between IL-13 (and IL-4) signaling and oxidative stress induces neuronal damage in vitro. In SA2, we will investigate the contribution of each of these cytokines to neuronal loss in vivo in a model of neuro-inflammation. In SA3, we will determine the cellular source of IL-13 and IL-4 during inflammation. These studies are highly relevant to understanding the role of inflammation in the pathogenesis of PD and may identify novel therapeutic targets for the treatment of this disease.
描述(由申请人提供):我们假设抗炎细胞因子IL-13和IL-4在黑质丘脑部(SNc)多巴胺能神经元死亡中起重要作用,这些细胞在人类帕金森病(PD)中丢失。该假设基于我们在小鼠中的初步研究,该研究显示白细胞介素13受体α 1链(IL-13 Ra 1)在SNc中的DA神经元中高度表达,并且该受体缺陷的小鼠被保护免于在用低剂量LPS进行慢性外周注射期间发生的多巴胺能(DA)神经元的损失。此外,使用多巴胺能细胞系的体外研究表明,虽然单独的IL-13对DA神经元没有有害作用,但它强烈增强了轻度氧化应激的毒性。用IL-4获得了类似的结果,IL-4是另一种能够激活IL-13 Ra 1依赖性信号传导的细胞因子。总之,这些结果表明,一种新的机制,抗炎细胞因子可以有助于神经元损失的条件下的压力。我们建议在三个具体目标中研究我们的假设。在SA 1中,我们将确定IL-13(和IL-4)信号和氧化应激之间的相互作用如何在体外诱导神经元损伤。在SA 2中,我们将在神经炎症模型中研究这些细胞因子中的每一种对体内神经元损失的贡献。在SA 3中,我们将确定炎症期间IL-13和IL-4的细胞来源。这些研究与了解炎症在PD发病机制中的作用高度相关,并可能为治疗这种疾病确定新的治疗靶点。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Neuroimmunology of the Interleukins 13 and 4.
- DOI:10.3390/brainsci6020018
- 发表时间:2016-06-13
- 期刊:
- 影响因子:3.3
- 作者:Mori S;Maher P;Conti B
- 通讯作者:Conti B
Deciphering the pathways that protect from IL-13-mediated potentiation of oxidative stress-induced dopaminergic nerve cell death.
- DOI:10.1016/j.cyto.2017.09.018
- 发表时间:2018-03
- 期刊:
- 影响因子:3.8
- 作者:Maher P;Conti B
- 通讯作者:Conti B
Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.
- DOI:10.1186/s12974-017-0862-1
- 发表时间:2017-04-21
- 期刊:
- 影响因子:9.3
- 作者:Mori S;Sugama S;Nguyen W;Michel T;Sanna MG;Sanchez-Alavez M;Cintron-Colon R;Moroncini G;Kakinuma Y;Maher P;Conti B
- 通讯作者:Conti B
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BRUNO CONTI其他文献
BRUNO CONTI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BRUNO CONTI', 18)}}的其他基金
Calorie Restriction, Body Temperature and Alzheimers Disease
热量限制、体温和阿尔茨海默病
- 批准号:
10727319 - 财政年份:2023
- 资助金额:
$ 42.21万 - 项目类别:
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
- 批准号:
10542643 - 财政年份:2022
- 资助金额:
$ 42.21万 - 项目类别:
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
- 批准号:
10190052 - 财政年份:2021
- 资助金额:
$ 42.21万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
8612661 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
9066821 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
8846153 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Role of the IL-13 system in dopaminergic cell death
IL-13系统在多巴胺能细胞死亡中的作用
- 批准号:
8724574 - 财政年份:2013
- 资助金额:
$ 42.21万 - 项目类别:
Brain interleukin-18 control of food intake and energy expenditure
脑白细胞介素 18 控制食物摄入和能量消耗
- 批准号:
8373865 - 财政年份:2012
- 资助金额:
$ 42.21万 - 项目类别:
相似海外基金
Development of small molecule inhibitors as anti-inflammatory agents and antidotes for arsenicals
开发作为抗炎剂和砷解毒剂的小分子抑制剂
- 批准号:
10727507 - 财政年份:2023
- 资助金额:
$ 42.21万 - 项目类别:
Discovery of New Anti-Inflammatory Agents to Treat COPD
发现治疗慢性阻塞性肺病的新型抗炎药
- 批准号:
9194162 - 财政年份:2016
- 资助金额:
$ 42.21万 - 项目类别:
Synthesis of anti-inflammatory agents and their structure-activity relationships studies
抗炎药的合成及其构效关系研究
- 批准号:
496858-2016 - 财政年份:2016
- 资助金额:
$ 42.21万 - 项目类别:
University Undergraduate Student Research Awards
NAAA Inhibitors as Anti-inflammatory Agents, Phase II
NAAA 抑制剂作为抗炎剂,II 期
- 批准号:
9201955 - 财政年份:2015
- 资助金额:
$ 42.21万 - 项目类别:
Novel flavonoids as anti-inflammatory agents in alcoholism
新型黄酮类化合物作为酒精中毒的抗炎剂
- 批准号:
8251289 - 财政年份:2014
- 资助金额:
$ 42.21万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8302750 - 财政年份:2012
- 资助金额:
$ 42.21万 - 项目类别:
Design and in vivo delivery of novel anti-inflammatory agents
新型抗炎剂的设计和体内递送
- 批准号:
267940 - 财政年份:2012
- 资助金额:
$ 42.21万 - 项目类别:
Operating Grants
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8403458 - 财政年份:2012
- 资助金额:
$ 42.21万 - 项目类别:
Development of inlammasome inhibitors to be used as anti-inflammatory agents
开发用作抗炎剂的inlammasome抑制剂
- 批准号:
8549297 - 财政年份:2012
- 资助金额:
$ 42.21万 - 项目类别:
TLR-7 Agonists as Targeted Anti-inflammatory Agents in Arthritis
TLR-7 激动剂作为关节炎的靶向抗炎药
- 批准号:
8472443 - 财政年份:2012
- 资助金额:
$ 42.21万 - 项目类别:














{{item.name}}会员




